Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Foote

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Nature Medicine|October 16, 2023
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockadeEmily C Harrold, Michael B Foote, Benoit Rousseau, et al.
The New England Journal of Medicine|April 28, 2025
Nonoperative Management of Mismatch Repair-Deficient TumorsAndrea Cercek, Michael B Foote, Benoit Rousseau, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.
Nature Communications|October 14, 2021
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.
Cancer Cell|June 13, 2025
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancerBenoit Rousseau, Mitesh Patel, Oliver Artz, et al.
Cancer Discovery|April 10, 2022
PD-1 Blockade in Solid Tumors with Defects in Polymerase EpsilonBenoit Rousseau, Ivan Bieche, Eric Pasmant, et al.
Nature Medicine|March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trialWungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Nature Medicine|October 16, 2023
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockadeEmily C Harrold, Michael B Foote, Benoit Rousseau, et al.
The New England Journal of Medicine|April 28, 2025
Nonoperative Management of Mismatch Repair-Deficient TumorsAndrea Cercek, Michael B Foote, Benoit Rousseau, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.
Nature Communications|October 14, 2021
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.
Cancer Cell|June 13, 2025
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancerBenoit Rousseau, Mitesh Patel, Oliver Artz, et al.
Cancer Discovery|April 10, 2022
PD-1 Blockade in Solid Tumors with Defects in Polymerase EpsilonBenoit Rousseau, Ivan Bieche, Eric Pasmant, et al.
Nature Medicine|March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trialWungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Pageof 6